View in EDS HTML Full Text PDF Full Text

An Anti-VEGF-B Antibody Reduces Abnormal Tumor Vasculature and Enhances the Effects of Chemotherapy.

Saved in:
Bibliographic Details
Title: An Anti-VEGF-B Antibody Reduces Abnormal Tumor Vasculature and Enhances the Effects of Chemotherapy.
Authors: Janes PW; Tumour Targeting Program, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3083, Australia., Parslow AC; Tumour Targeting Program, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia., Cao D; Tumour Targeting Program, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia., Rigopoulos A; Tumour Targeting Program, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia., Lee FT; Tumour Targeting Program, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia., Gong SJ; School of Computing, Engineering and Mathematical Sciences, La Trobe University, Melbourne, VIC 3083, Australia.; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC 3084, Australia., Cartwright GA; Tumour Targeting Program, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia., Burvenich IJG; Tumour Targeting Program, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3083, Australia., Eriksson U; Division of Vascular Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, 171 77 Solna, Sweden., Johns TG; Oncogenic Signalling Laboratory, Telethon Kids Cancer Centre, Telethon Kids Institute, Nedlands, WA 6009, Australia.; Medical School, University of Western Australia, Crawley, WA 6009, Australia., Scott FE; Tumour Targeting Program, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia., Scott AM; Tumour Targeting Program, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3083, Australia.; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC 3084, Australia.; Department of Medicine, University of Melbourne, Parkville, VIC 3052, Australia.
Source: Cancers [Cancers (Basel)] 2024 May 16; Vol. 16 (10). Date of Electronic Publication: 2024 May 16.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38791979
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: An Anti-VEGF-B Antibody Reduces Abnormal Tumor Vasculature and Enhances the Effects of Chemotherapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Janes+PW%22">Janes PW</searchLink>; Tumour Targeting Program, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3083, Australia.<br /><searchLink fieldCode="AU" term="%22Parslow+AC%22">Parslow AC</searchLink>; Tumour Targeting Program, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia.<br /><searchLink fieldCode="AU" term="%22Cao+D%22">Cao D</searchLink>; Tumour Targeting Program, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia.<br /><searchLink fieldCode="AU" term="%22Rigopoulos+A%22">Rigopoulos A</searchLink>; Tumour Targeting Program, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia.<br /><searchLink fieldCode="AU" term="%22Lee+FT%22">Lee FT</searchLink>; Tumour Targeting Program, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia.<br /><searchLink fieldCode="AU" term="%22Gong+SJ%22">Gong SJ</searchLink>; School of Computing, Engineering and Mathematical Sciences, La Trobe University, Melbourne, VIC 3083, Australia.; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC 3084, Australia.<br /><searchLink fieldCode="AU" term="%22Cartwright+GA%22">Cartwright GA</searchLink>; Tumour Targeting Program, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia.<br /><searchLink fieldCode="AU" term="%22Burvenich+IJG%22">Burvenich IJG</searchLink>; Tumour Targeting Program, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3083, Australia.<br /><searchLink fieldCode="AU" term="%22Eriksson+U%22">Eriksson U</searchLink>; Division of Vascular Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, 171 77 Solna, Sweden.<br /><searchLink fieldCode="AU" term="%22Johns+TG%22">Johns TG</searchLink>; Oncogenic Signalling Laboratory, Telethon Kids Cancer Centre, Telethon Kids Institute, Nedlands, WA 6009, Australia.; Medical School, University of Western Australia, Crawley, WA 6009, Australia.<br /><searchLink fieldCode="AU" term="%22Scott+FE%22">Scott FE</searchLink>; Tumour Targeting Program, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia.<br /><searchLink fieldCode="AU" term="%22Scott+AM%22">Scott AM</searchLink>; Tumour Targeting Program, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3083, Australia.; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC 3084, Australia.; Department of Medicine, University of Melbourne, Parkville, VIC 3052, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101526829%22">Cancers</searchLink> [Cancers (Basel)] 2024 May 16; Vol. 16 (10). <i>Date of Electronic Publication: </i>2024 May 16.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101526829 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2072-6694 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220726694%22">20726694 </searchLink><i>NLM ISO Abbreviation: </i>Cancers (Basel) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38791979
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/cancers16101902
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: An Anti-VEGF-B Antibody Reduces Abnormal Tumor Vasculature and Enhances the Effects of Chemotherapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Janes PW
      – PersonEntity:
          Name:
            NameFull: Parslow AC
      – PersonEntity:
          Name:
            NameFull: Cao D
      – PersonEntity:
          Name:
            NameFull: Rigopoulos A
      – PersonEntity:
          Name:
            NameFull: Lee FT
      – PersonEntity:
          Name:
            NameFull: Gong SJ
      – PersonEntity:
          Name:
            NameFull: Cartwright GA
      – PersonEntity:
          Name:
            NameFull: Burvenich IJG
      – PersonEntity:
          Name:
            NameFull: Eriksson U
      – PersonEntity:
          Name:
            NameFull: Johns TG
      – PersonEntity:
          Name:
            NameFull: Scott FE
      – PersonEntity:
          Name:
            NameFull: Scott AM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 16
              M: 05
              Text: 2024 May 16
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 2072-6694
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Cancers
              Type: main
ResultId 1